Hoth Therapeutics: FDA Grants Pre-IND Meeting For HT-KIT; Stock Surges
Hoth Therapeutics, Inc. (HOTH) announced the Pre-IND meeting previously requested for HT-KIT with the FDA has been granted to receive written responses only from the FDA that are targeted for delivery on November 7, 2023.